A carregar...
Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study.
Forty patients were entered into a randomised placebo controlled crossover study to assess the efficacy and safety of oral acyclovir 200 mg four times a day in the prophylaxis of recurrent genital herpes. Each treatment began during a recurrence and continued for a maximum of 84 days or until the on...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1985
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1011866/ https://ncbi.nlm.nih.gov/pubmed/3910546 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|